bioRxiv · 5 Nov 2026
Gut Roseburia hominis-derived 10-hydroxystearic acid alleviates metabolic disorder by restoring hepatic fatty acid metabolism
Jingxiang Zhang, Chunlei Zhang, Clare Hsu, Minting Hu, Ling Hu, Shaun Tan, Kazuyuki Kasahara, Yifei Ge, Shuli Zhang, Sunny Wong, Rinkoo Dalan, Nguan Soon Tan, Yusuf Ali, Ju-Sheng Zheng, Chuchu Wang, Xiaotao Shen
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Metabolic disorders and health-promoting dietary interventions represent complementary contexts of metabolic impairment and improvement, providing an opportunity to identify gut microbial taxa associated with both disease status and dietary response. Here, we integrated five independent human cohorts spanning metabolic disorders and dietary interventions and identified Roseburia hominis as a gut microbial taxon that consistently decreased in metabolic disorders and increased after dietary interventions. Beyond species abundance, strain-level genetic variation in R. hominis provided additional information for distinguishing metabolic disorder status and stratifying cardiometabolic severity. Integration of phenotype-associated variants with circulating metabolomics prioritized ohyA, encoding an oleate hydratase, as a candidate functional determinant linking R. hominis genetic variation to host metabolic heterogeneity. An ohyA-based genetic burden score was associated with adverse cardiometabolic traits and changed longitudinally during dietary intervention, while circulating metabolites statistically accounted for part of the associations between ohyA variants and host phenotypes. Functional experiments demonstrated that R. hominis OhyA protein converts oleic acid to 10-hydroxystearic acid (10-HSA), whereas an OhyA carrying five prioritized missense substitutions showed markedly impaired enzymatic activity. In high-fat diet-fed mice, 10-HSA attenuated body-weight gain, improved glucose homeostasis and insulin sensitivity, and reduced dyslipidemia and hepatic steatosis. Multi-omics profiling revealed limited remodeling of the gut microbiota but pronounced hepatic transcriptional and metabolic responses, characterized by activation of PPARα-associated lipid-metabolic pathways, altered fatty-acid oxidation and desaturation, and remodeling of hepatic lipid composition. Together, these findings establish a diet-responsive R. hominis-OhyA-10-HSA axis linking microbial variation to host metabolic dysfunction and show that 10-HSA can improve metabolic health in mice.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (0)
What it cites, from open citation data, with Crossref's record of each.